Cellusion

About:

Cellusion is a biotechnology research firm that focuses on corneal endothelial regenerative medicine intended to improve eye vision.

Website: https://cellusion.jp/en

Top Investors: SMBC Venture Capital, Nissay Capital, UTEC - The University of Tokyo Edge Capital Partners, JIC Venture Growth Investments, DBJ Capital

Description:

Cellusion is a regenerative medicine startup from Keio University. The mission of Cellusion is to deliver novel therapies for all bullous keratopathy patients by our iPS cells origin corneal endothelial cells mass culture system.